FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003134712> ?p ?o ?g. }

• W2003134712 endingPage "S48" @default.
• W2003134712 startingPage "S43" @default.
• W2003134712 abstract "Narcolepsy, a lifelong disorder, requires long-term management of symptoms. Interventions may be nonpharmacologic, such as lifestyle changes, and pharmacologic for relief of daytime sleepiness. Pharmacologic treatment of narcolepsy has depended on the use of CNS stimulants to increase wakefulness, vigilance, and performance. The medications considered effective in the treatment of narcolepsy include dextroamphetamine, pemoline, methylphenidate, methamphetamine, and modafinil; only methylphenidate hydrochloride and dextroamphetamine are approved for use in the United States. The currently available stimulants are associated with sympathomimetic side effects, limitations in efficacy, and negative effects on nighttime sleep. This has led to the development of alternative agents. Modafinil, a new wake-promoting agent, has been shown to be effective in reducing daytime sleepiness in patients with narcolepsy. The results of a United States 18-center randomized, placebo-controlled, 9-week trial of modafinil in the treatment of patients with narcolepsy has recently been reported. Patients receiving modafinil demonstrated significant improvement in all subjective and objective measures of sleepiness. Treatment with modafinil 200 mg and 400 mg daily significantly reduced mean scores on the Epworth Sleepiness Scale compared with baseline and placebo (<i>p</i> < 0.001) and significantly increased mean scores on the Maintenance of Wakefulness Test (<i>p</i> < 0.001) and the Multiple Sleep Latency Test (<i>p</i> < 0.01) compared with baseline and placebo. More improvement, as recorded on the Clinical Global Impression of Change scale, was seen in the modafinil group than in the placebo group at all time points (<i>p</i> < 0.001). Modafinil was well tolerated, with headache the only adverse event to occur significantly more often in the active treatment group (<i>p</i> < 0.05). These results suggest that modafinil is an important new therapeutic option for the treatment of narcolepsy." @default.
• W2003134712 created "2016-06-24" @default.
• W2003134712 creator A5038368948 @default.
• W2003134712 date "1998-02-01" @default.
• W2003134712 modified "2023-10-15" @default.
• W2003134712 title "Treatment modalities for narcolepsy" @default.
• W2003134712 cites W1964152794 @default.
• W2003134712 cites W2336714276 @default.
• W2003134712 cites W34681802 @default.
• W2003134712 doi "https://doi.org/10.1212/wnl.50.2_suppl_1.s43" @default.
• W2003134712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9484423" @default.
• W2003134712 hasPublicationYear "1998" @default.
• W2003134712 type Work @default.
• W2003134712 sameAs 2003134712 @default.
• W2003134712 citedByCount "209" @default.
• W2003134712 countsByYear W20031347122012 @default.
• W2003134712 countsByYear W20031347122013 @default.
• W2003134712 countsByYear W20031347122015 @default.
• W2003134712 countsByYear W20031347122016 @default.
• W2003134712 countsByYear W20031347122018 @default.
• W2003134712 countsByYear W20031347122020 @default.
• W2003134712 countsByYear W20031347122021 @default.
• W2003134712 countsByYear W20031347122022 @default.
• W2003134712 crossrefType "journal-article" @default.
• W2003134712 hasAuthorship W2003134712A5038368948 @default.
• W2003134712 hasConcept C118552586 @default.
• W2003134712 hasConcept C126322002 @default.
• W2003134712 hasConcept C142724271 @default.
• W2003134712 hasConcept C1513209611 @default.
• W2003134712 hasConcept C15744967 @default.
• W2003134712 hasConcept C197934379 @default.
• W2003134712 hasConcept C204787440 @default.
• W2003134712 hasConcept C27081682 @default.
• W2003134712 hasConcept C2776145449 @default.
• W2003134712 hasConcept C2777112843 @default.
• W2003134712 hasConcept C2777193897 @default.
• W2003134712 hasConcept C2778205975 @default.
• W2003134712 hasConcept C2778664715 @default.
• W2003134712 hasConcept C2779034229 @default.
• W2003134712 hasConcept C2779320081 @default.
• W2003134712 hasConcept C2779494582 @default.
• W2003134712 hasConcept C2780163352 @default.
• W2003134712 hasConcept C2780557958 @default.
• W2003134712 hasConcept C2780714222 @default.
• W2003134712 hasConcept C2780783007 @default.
• W2003134712 hasConcept C2781210498 @default.
• W2003134712 hasConcept C2781326671 @default.
• W2003134712 hasConcept C2781433485 @default.
• W2003134712 hasConcept C42219234 @default.
• W2003134712 hasConcept C513476851 @default.
• W2003134712 hasConcept C522805319 @default.
• W2003134712 hasConcept C71924100 @default.
• W2003134712 hasConceptScore W2003134712C118552586 @default.
• W2003134712 hasConceptScore W2003134712C126322002 @default.
• W2003134712 hasConceptScore W2003134712C142724271 @default.
• W2003134712 hasConceptScore W2003134712C1513209611 @default.
• W2003134712 hasConceptScore W2003134712C15744967 @default.
• W2003134712 hasConceptScore W2003134712C197934379 @default.
• W2003134712 hasConceptScore W2003134712C204787440 @default.
• W2003134712 hasConceptScore W2003134712C27081682 @default.
• W2003134712 hasConceptScore W2003134712C2776145449 @default.
• W2003134712 hasConceptScore W2003134712C2777112843 @default.
• W2003134712 hasConceptScore W2003134712C2777193897 @default.
• W2003134712 hasConceptScore W2003134712C2778205975 @default.
• W2003134712 hasConceptScore W2003134712C2778664715 @default.
• W2003134712 hasConceptScore W2003134712C2779034229 @default.
• W2003134712 hasConceptScore W2003134712C2779320081 @default.
• W2003134712 hasConceptScore W2003134712C2779494582 @default.
• W2003134712 hasConceptScore W2003134712C2780163352 @default.
• W2003134712 hasConceptScore W2003134712C2780557958 @default.
• W2003134712 hasConceptScore W2003134712C2780714222 @default.
• W2003134712 hasConceptScore W2003134712C2780783007 @default.
• W2003134712 hasConceptScore W2003134712C2781210498 @default.
• W2003134712 hasConceptScore W2003134712C2781326671 @default.
• W2003134712 hasConceptScore W2003134712C2781433485 @default.
• W2003134712 hasConceptScore W2003134712C42219234 @default.
• W2003134712 hasConceptScore W2003134712C513476851 @default.
• W2003134712 hasConceptScore W2003134712C522805319 @default.
• W2003134712 hasConceptScore W2003134712C71924100 @default.
• W2003134712 hasIssue "Issue 2, Supplement 1" @default.
• W2003134712 hasLocation W20031347121 @default.
• W2003134712 hasLocation W20031347122 @default.
• W2003134712 hasOpenAccess W2003134712 @default.
• W2003134712 hasPrimaryLocation W20031347121 @default.
• W2003134712 hasRelatedWork W1241659441 @default.
• W2003134712 hasRelatedWork W1599894749 @default.
• W2003134712 hasRelatedWork W190872974 @default.
• W2003134712 hasRelatedWork W1963854292 @default.
• W2003134712 hasRelatedWork W1978869736 @default.
• W2003134712 hasRelatedWork W1992058738 @default.
• W2003134712 hasRelatedWork W1994439753 @default.
• W2003134712 hasRelatedWork W3037606875 @default.
• W2003134712 hasRelatedWork W4302231038 @default.
• W2003134712 hasRelatedWork W29009247 @default.
• W2003134712 hasVolume "50" @default.
• W2003134712 isParatext "false" @default.
• W2003134712 isRetracted "false" @default.
• W2003134712 magId "2003134712" @default.

• next